Dynavax Technologies Corporation (DVAX)

Profitability ratios

Return on sales

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Gross profit margin 11.76% 45.03% 36.11% -104.61% -410.77%
Operating profit margin -15.75% 39.22% 30.90% -162.61% -646.95%
Pretax margin -1.86% 40.71% 17.81% -178.95% -732.14%
Net profit margin -2.72% 40.55% 17.63% -178.95% -732.14%

The profitability ratios of Dynavax Technologies Corp. show a significant fluctuation over the past five years. The gross profit margin has been generally increasing, reaching its highest level in 2023 at 78.40%, indicating efficient cost management in its production process. However, the operating profit margin and pretax margin experienced significant volatility, with negative margins observed in 2020 and 2019 due to operational challenges and losses. In contrast, 2022 and 2021 saw positive margins, reflecting improved operational performance and better cost controls.

The net profit margin, which accounts for all expenses including taxes and interest, also exhibited fluctuations, with negative margins seen in 2020 and 2019 due to substantial losses. The company managed to achieve a positive net profit margin in 2021 and 2022, indicating a turnaround in its profitability. However, in 2023, the net profit margin turned negative again, suggesting challenges in generating bottom-line profits despite improvements in gross profit.

Overall, Dynavax Technologies Corp. has shown improvements in managing its costs and operating efficiency over the years, but continued efforts may be needed to ensure sustained profitability and financial health in the future.


Return on investment

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Operating return on assets (Operating ROA) -3.71% 28.76% 12.94% -19.35% -48.32%
Return on assets (ROA) -0.64% 29.74% 7.38% -21.30% -54.68%
Return on total capital 0.38% 51.81% 39.89% -23.55% -72.57%
Return on equity (ROE) -1.03% 50.46% 34.50% -128.19% -1,840.77%

Looking at the profitability ratios of Dynavax Technologies Corp. over the past five years, we see mixed performance:

1. Operating return on assets (Operating ROA):
- The Operating ROA fluctuated significantly over the period, ranging from -43.53% in 2019 to a high of 28.66% in 2022.
- The negative Operating ROA in 2020 and 2023 indicates that the company's core operations did not generate sufficient profits relative to its total assets during those years.

2. Return on assets (ROA):
- The ROA also showed variability, with a notable peak of 29.71% in 2022.
- Similar to the Operating ROA, the negative ROA in 2020 and 2023 suggests that the company struggled to generate profits from its total assets during those periods.

3. Return on total capital:
- The return on total capital indicates how well the company generated profits from both its equity and debt capital.
- While there was a positive return in most years, the negative values in 2020 and 2023 are concerning as they suggest that the company may not have effectively utilized its capital to generate returns.

4. Return on equity (ROE):
- The ROE had a similar pattern to the other ratios, showing significant fluctuations over the years.
- The negative ROE in 2019 and 2020, as well as the extremely low value in 2021, signify that the company struggled to generate adequate returns for its equity shareholders during those periods.

Overall, Dynavax Technologies Corp. experienced variability in its profitability ratios over the past five years, with some years showing strong performance while others were marked by difficulties in generating returns from assets, capital, and equity. Further analysis of the company's financial strategy and operations may be necessary to understand the underlying reasons for these fluctuations.